BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6363150)

  • 1. Direct immunofluorescence in recurrent aphthous ulcers and Behçet's disease.
    Reimer G; Luckner L; Hornstein OP
    Dermatologica; 1983; 167(6):293-8. PubMed ID: 6363150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behçet's disease.
    Sun A; Chang JG; Kao CL; Liu BY; Wang JT; Chu CT; Yuan JH; Chiang CP
    J Oral Pathol Med; 1996 May; 25(5):212-8. PubMed ID: 8835817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apthae: histologic, immunofluorescent and immuno--electron microscopy study of their pathogenesis].
    Luderschmidt C; Wolff HH; Scherer R
    Hautarzt; 1981 Jul; 32(7):364-9. PubMed ID: 7021477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms.
    Rhee SH; Kim YB; Lee ES
    J Korean Med Sci; 2005 Dec; 20(6):971-6. PubMed ID: 16361807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of mucocutaneous lesions in Behçet's disease.
    Inoue C; Itoh R; Kawa Y; Mizoguchi M
    J Dermatol; 1994 Jul; 21(7):474-80. PubMed ID: 8089366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative immunopathologic study of oral aphthae, non-involved mucosa from aphthae patients, healthy mucosa and trauma-induced ulcers].
    Barnadas M; Rodríguez JL; Gelpi C; de Moragas JM
    Med Cutan Ibero Lat Am; 1985; 13(5):391-9. PubMed ID: 3914590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evidence for an association of Epstein-Barr virus with pre-ulcerative oral lesions in patients with recurrent aphthous ulcers or Behçet's disease.
    Sun A; Chang JG; Chu CT; Liu BY; Yuan JH; Chiang CP
    J Oral Pathol Med; 1998 Apr; 27(4):168-75. PubMed ID: 9563572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A, B (Class I) and HLA-DR, DQ (Class II) antigens in Turkish patients with recurrent aphthous ulceration and Behçet's disease.
    Pekiner FN; Aytugar E; Demirel GY; Borahan MO
    Med Princ Pract; 2013; 22(5):464-8. PubMed ID: 23485763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of circulating IgG, IgA, IgM, complement and immune complexes in lichen planus, Behcet's disease and recurrent aphthae].
    Zheng JL
    Zhonghua Kou Qiang Ke Za Zhi; 1986 May; 21(3):165-7. PubMed ID: 3463491
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant and Fibrinolytic Disorders in Patients with Behçet's Disease and Recurrent Aphthous Ulcer.
    Shang H; Ye JJ; Ji M; Wang FF; Zhu YY; Qi XM
    Chin J Physiol; 2011 Aug; 54(4):235-40. PubMed ID: 22129821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of Behçet's disease associated with membranous nephropathy.
    Miura M; Tomino Y; Suga T; Endoh M; Nomoto Y; Sakai H; Furuya K; Kobayashi Y
    Tokai J Exp Clin Med; 1984 Aug; 9(3):231-5. PubMed ID: 6537671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
    Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
    Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.
    Pekiner FN; Aytugar E; Demirel GY; Borahan MO
    J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease.
    Lee JH; Jung JY; Bang D
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
    Levinsky RJ; Lehner T
    Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposits of immunoglobulin G and complement C3 in recurrent aphthous ulcerations.
    Donatsky O; Dabelsteen E
    Scand J Dent Res; 1977 Sep; 85(6):419-25. PubMed ID: 339319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic effect of cytotoxic lymphocytes on oral epithelial cells in Behçet's disease.
    Reimer G; Steinkohl S; Djawari D; Hornstein OP
    Br J Dermatol; 1982 Nov; 107(5):529-36. PubMed ID: 6982060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease.
    Oh SH; Han EC; Lee JH; Bang D
    Clin Exp Dermatol; 2009 Aug; 34(6):e208-12. PubMed ID: 19549229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possibility of a viral etiology in recurrent aphthous ulcers and Behçet's syndrome.
    Hooks JJ
    J Oral Pathol; 1978; 7(6):353-64. PubMed ID: 105094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes in Behçet's syndrome and recurrent oral ulceration.
    Williams BD; Lehner T
    Br Med J; 1977 May; 1(6073):1387-9. PubMed ID: 324574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.